34
Participants
Start Date
June 8, 2020
Primary Completion Date
March 30, 2022
Study Completion Date
March 30, 2022
Interleukin-7
Intramuscular (IM) administration of CYT107 at 3 μg/ kg followed, after 48hrs of observation, by 10 μg/kg twice a week for 2 weeks or
Placebo
Intramuscular (IM) placebo (normal saline) at the same frequency
Chru Tours, Tours
Chr Orleans La Source, Orléans
Hôpital Edouard Herriot, Lyon
hopital Edouard Herriot, Lyon
hopital COCHIN, Paris
University Hospital of Limoges, Limoges
Collaborators (1)
University Hospital, Limoges
OTHER
Amarex Clinical Research
OTHER
Revimmune
INDUSTRY